Earningsreport

Q2/2024 6/30/2024 EPS -1.190 ZacksConsensus -1.150 ActVsEst (0.040) - Miss

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx